These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16839375)

  • 1. More on: factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control "NOHA First" study.
    Lissalde-Lavigne G; Fabbro-Peray P; Marès P; Gris JC
    J Thromb Haemost; 2006 Jul; 4(7):1640-2. PubMed ID: 16839375
    [No Abstract]   [Full Text] [Related]  

  • 2. More on: factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first-intended pregnancy: the matched case-control 'NOHA first' study.
    Grandone E; Colaizzo D; Tiscia G; Margaglione M
    J Thromb Haemost; 2006 Mar; 4(3):709-10. PubMed ID: 16460470
    [No Abstract]   [Full Text] [Related]  

  • 3. Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control 'NOHA first' study.
    Lissalde-Lavigne G; Fabbro-Peray P; Cochery-Nouvellon E; Mercier E; Ripart-Neveu S; Balducchi JP; Daurès JP; Perneger T; Quéré I; Dauzat M; Marès P; Gris JC
    J Thromb Haemost; 2005 Oct; 3(10):2178-84. PubMed ID: 16194196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey.
    Altintas A; Pasa S; Akdeniz N; Cil T; Yurt M; Ayyildiz O; Batun S; Isi H
    Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations.
    DeSancho MT; Berlus N; Christos PJ; Rand J
    Blood Coagul Fibrinolysis; 2010 Jan; 21(1):11-5. PubMed ID: 19474699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of the subsequent pregnancy after a first loss in women with factor V Leiden or prothrombin 20210A mutation: a rebuttal.
    Lissalde-Lavigne G; Marès P; Quéré I; Gris JC
    J Thromb Haemost; 2007 Sep; 5(9):1990-2; author reply 1992-4. PubMed ID: 17723143
    [No Abstract]   [Full Text] [Related]  

  • 7. Factor V Leiden and prothrombin G20210A mutations in pregnancies with adverse outcome.
    Agorastos T; Karavida A; Lambropoulos A; Constantinidis T; Tzitzimikas S; Chrisafi S; Saravelos H; Vavilis D; Kotsis A; Bontis J
    J Matern Fetal Neonatal Med; 2002 Oct; 12(4):267-73. PubMed ID: 12572596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of placenta-mediated pregnancy complications or pregnancy-related VTE in VTE-asymptomatic families of probands with VTE and heterozygosity for factor V Leiden or G20210 prothrombin mutation.
    Cordoba I; Pegenaute C; González-López TJ; Chillon C; Sarasquete ME; Martin-Herrero F; Guerrero C; Cabrero M; Garcia Sanchez MH; Pabon P; Lozano FS; Gonzalez M; Alberca I; González-Porras JR
    Eur J Haematol; 2012 Sep; 89(3):250-5. PubMed ID: 22642978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of venous thrombosis in pregnancy among carriers of the factor V Leiden and the prothrombin gene G20210A polymorphisms.
    Jacobsen AF; Dahm A; Bergrem A; Jacobsen EM; Sandset PM
    J Thromb Haemost; 2010 Nov; 8(11):2443-9. PubMed ID: 20735725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy-associated venous thromboembolism in combined heterozygous factor V Leiden and prothrombin G20210A mutations.
    Couto E; Nomura ML; Barini R; Pinto e Silva JL
    Sao Paulo Med J; 2005 Nov; 123(6):286-8. PubMed ID: 16444389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Factor V Leiden and prothrombin G20210A mutations in Sudanese women with severe preeclampsia.
    Elzein HO; Saad AA; Yousif AA; Elamin E; Abdalhabib EK; Elzaki SG
    Curr Res Transl Med; 2020 Apr; 68(2):77-80. PubMed ID: 31501046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor V Leiden and G20210A prothrombin mutations are risk factors for very early recurrent miscarriage.
    Reznikoff-Etiévan MF; Cayol V; Carbonne B; Robert A; Coulet F; Milliez J
    BJOG; 2001 Dec; 108(12):1251-4. PubMed ID: 11843387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
    Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY
    Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of thrombophilic mutations related to spontaneous abortions by a multiplex SNaPshot method.
    Madjunkova S; Volk M; Peterlin B; Plaseska-Karanfilska D
    Genet Test Mol Biomarkers; 2012 Apr; 16(4):259-64. PubMed ID: 22023244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor V leiden and prothrombin G20210A mutations, but not methylenetetrahydrofolate reductase C677T, are associated with recurrent miscarriages.
    Foka ZJ; Lambropoulos AF; Saravelos H; Karas GB; Karavida A; Agorastos T; Zournatzi V; Makris PE; Bontis J; Kotsis A
    Hum Reprod; 2000 Feb; 15(2):458-62. PubMed ID: 10655323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Third trimester nonrecurrent fetal loss is associated with factor V Leiden and prothrombin gene mutations.
    Karateke A; Haliloglu B; Gurbuz A
    J Matern Fetal Neonatal Med; 2005 Nov; 18(5):299-304. PubMed ID: 16390788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies.
    Rodger MA; Betancourt MT; Clark P; Lindqvist PG; Dizon-Townson D; Said J; Seligsohn U; Carrier M; Salomon O; Greer IA
    PLoS Med; 2010 Jun; 7(6):e1000292. PubMed ID: 20563311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prothrombin gene G20210A mutation and obstetric complications.
    Silver RM; Zhao Y; Spong CY; Sibai B; Wendel G; Wenstrom K; Samuels P; Caritis SN; Sorokin Y; Miodovnik M; O'Sullivan MJ; Conway D; Wapner RJ;
    Obstet Gynecol; 2010 Jan; 115(1):14-20. PubMed ID: 20027028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden G1691A and factor II G20210A point mutations and pregnancy in North-West of Iran.
    Bagheri M; Rad IA; Nanbakhsh F
    Arch Gynecol Obstet; 2011 Nov; 284(5):1311-5. PubMed ID: 21773779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence of hereditary thrombophilia in women with pregnancy loss in multi-center studies in Poland].
    Skrzypczak J; Rajewski M; Wirstlein P; Goździewicz T; Breborowicz G; Leszczyńska-Gorzelak B; Ludwikowski G; Preis K; Wołczyński S; Zimmer M
    Ginekol Pol; 2012 May; 83(5):330-6. PubMed ID: 22708328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.